Why you need to buy Tic Tac’s brand-new vaccine for COVID-19, a $1.9M rebate
The U.S. government is giving a $600,000 rebate to every pharmacist who sells a Tic-Tac vaccine to help cover the cost of a new, $1 billion vaccine.
The vaccine, developed by Pfizer and TicTac, will be distributed to pharmacies nationwide as soon as the manufacturer has received the government’s final approval for distribution, said Kathleen McBride, a spokeswoman for the U.K. Department of Health.
Pfizer is providing the vaccine in the U-shaped “T” shape, which the manufacturer uses to distribute its drugs.
The U.N. agency will also waive the cost for the vaccine if a pharmacy in the country can’t get the vaccine from Pfizer.
The federal government says it has given $2.2 billion in direct grants since the outbreak began.
The program also pays for vaccines for people in the developing world, and it pays for medicines to help prevent infections.
The U-shape vaccine has the lowest number of doses available in the United States.
A Tic Tac vaccine was first introduced in 1997.
The brand now includes products for children and adults, including a vaccine for respiratory infections, diarrhea, and pneumonia.
It’s also available for other common diseases, including heart disease and cancer.
The company is also working on a vaccine that might include a booster shot to help children with other cancers, such as lymphoma.
The first Tic Tec vaccine was distributed in July and will be sold through Pfizer, according to a release from the Centers for Medicare and Medicaid Services.